Tue, Mar 3, 2015, 11:08 AM EST - U.S. Markets close in 4 hrs 52 mins


% | $
Quotes you view appear here for quick access.

Halozyme Therapeutics, Inc. Message Board

  • audphil78 audphil78 Feb 26, 2013 1:38 AM Flag

    Took 10.5% Bank Loan and mortgaged the entire company

    Basically the bank loan they took out was a 'bet the company" loan. If they can't get to cash flow positive in time they either dilute like crazy or the bank owns the company.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, that is definitely scary!! My guess is that this is what spooked large investors today even more than the Jeffries call.

    • Halozyme Therapeutics Issues Financial Guidance For 2013
      SAN DIEGO, Jan. 7, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care, today announced that the Company ended 2012 with a cash balance of approximately $100 million and expects 2013 net cash burn to be between $45 and $50 million. The Company also announced it secured a $30 million term loan from Oxford Finance and Silicon Valley Bank.
      so let's see- 100M balance with money coming in from Pfizer and Roche- bridge loan of 30M to avoid dilution- a stockholder friendly strategy if you ask me- most biotechs couldn't care less and just set up an ATM or secondary- thanks Greg.

14.87-0.35(-2.30%)11:08 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.